Andrew Balo

Andrew Balo

Director/Board Member at GLUCOTRACK, INC.

Net worth: 3 097 $ as of 2026-05-30

78 year
Health Technology
Consumer Services

Profile

Mr. Andrew K. Balo is an EVP-Clinical Affairs, Regulatory Strategy at DexCom, Inc. Mr. Balo was previously employed as a Vice President-Regulatory & Clinical Affairs by InnerCool Therapies, Inc., a VP-Quality, Regulatory & Clinical Affairs by St. Jude Medical LLC, and a Vice President-Rgulatory & Clinical Affairs by Endocardial Solutions, Inc. He received his undergraduate degree from the University of Maryland.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-01-27 4,692 ( 0.07% ) 3 097 $ 2026-05-30

Andrew Balo active positions

CompaniesPositionStart
GLUCOTRACK, INC. Director/Board Member 2024-06-13

Former positions of Andrew Balo

CompaniesPositionEnd
DEXCOM, INC. Chief Tech/Sci/R&D Officer 2024-03-23
DexCom International Ltd.
Chief Tech/Sci/R&D Officer 2024-03-23
Chief Tech/Sci/R&D Officer 2002-01-31
ST JUDE MEDICAL INC Chief Tech/Sci/R&D Officer 1996-12-31
Chief Tech/Sci/R&D Officer -
See the detail of Andrew Balo's experience

Training of Andrew Balo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

DexCom International Ltd.